Market Research > Industries > Chemicals

Market Research: The Global Outlook for Specialty Excipients for Oral Solid-Dosage-Form Pharmaceuticals, Volume I: United States

The Global Outlook for Specialty Excipients for Oral Solid-Dosage-Form Pharmaceuticals, Volume I: United States - Archived Report

Published March 2003

View PDF brochure

This report, the first of two regional volumes, provides a comprehensive examination of the complex and fragmented global market for oral solid-dosage products. It features distinct and detailed analyses of four major specialty excipient categories and more than 25 individual products, based on 2003 data. Key industry dynamics, government regulations, and trends are also examined in each volume. Detailed assessments of specialty excipient procurement practices and business profiles of leading and niche specialty excipient and delivery technology suppliers in the United States are provided. An overall business outlook and appraisal with a five-year forecast complete each regional volume. (Y540)

	ORDER ONLINE

You may submit an online request to subscribe to sections of this report, using a simple three-step process. After submitting your online request, you will then be contacted by a member of our global sales team to confirm the final price, and complete the transaction. Upon acceptance of your order, we will deliver the files in pdf format via email.

STEP 1 of 3

– Select the sections in which you are interested by clicking on the appropriate boxes:

FULL REPORT [US$ 27 500 (twenty seven thousand five hundred US Dollars)]

INTRODUCTION [US$ 0]

Table 2-1 SELECTED SPECIALTY EXCIPIENTS COVERED IN THIS STUDY BY PRODUCT CLASS, 2003
Table 2-2 COMMON ABBREVIATIONS AND ACRONYMS USED IN THIS REPORT

PHARMACEUTICAL INDUSTRY OVERVIEW [US$ 700]

Table 3-1 SELECTED MAJOR PRESCRIPTION THERAPEUTIC CLASSES AND ASSOCIATED MEDICAL CONDITIONS, 2003
Table 3-2 SELECTED MAJOR NONPRESCRIPTION DRUG CLASSES AND CATEGORIES WITH ASSOCIATED MEDICAL CONDITIONS, 2003
Figure 3-1 GROWTH IN WORLDWIDE MANUFACTURERS’ SALES OF PRESCRIPTION PHARMACEUTICALS BY REGION, 2002
Table 3-3 WORLDWIDE MANUFACTURERS’ SALES OF PRESCRIPTION PHARMACEUTICALS FOR THE TOP 50 COMPANIES, 2002
Table 3-4 WORLDWIDE HEALTHCARE RESEARCH AND DEVELOPMENT SPENDING AND SHARE OF RX DRUG SALES FOR THE TOP 50 COMPANIES, 2002
Table 3-5 WORLDWIDE MANUFACTURERS’ SALES OF LEADING PRESCRIPTION OSDF PRODUCTS FOR THE TOP 15 PHARMACEUTICAL COMPANIES, 2002
Table 3-6 MANUFACTURERS’ SALES FOR TOP 10 COMPANIES IN THE U.S. PRESCRIPTION PHARMACEUTICAL MARKET, WITH SHARE AND GROWTH, 2002
Table 3-7 MANUFACTURERS’ SALES FOR THE TOP 10 THERAPEUTIC CLASSES IN THE U.S. PRESCRIPTION PHARMACEUTICAL MARKET, WITH SHARE AND GROWTH, 2002
Table 3-8 MANUFACTURERS’ SALES FOR THE TOP 10 PRESCRIPTION PHARMACEUTICAL PRODUCERS IN THE U.S. MARKET, WITH SHARE AND GROWTH, 2002
Table 3-9 TOP 10 U.S. MANUFACTURERS’ SALES OF OTC ORAL SOLID-DOSAGE FORMS, 2002
Table 3-10 SALES OF LEADING U.S. MANUFACTURERS OF OTC ORAL SOLID-DOSAGE FORMS BY PRODUCT CLASS, 2002
Table 3-11 LEADING NONPRESCRIPTION OSDF PRODUCTS FOR THE TOP 10 OTC COMPANIES, 2002
Table 3-12 SELECTED GENERIC/PRIVATE LABEL COMPANIES OWNED BY OTHER COMPANIES, 2003

SPECIALTY BINDERS AND FILLERS [US$ 6 875]

Table 4-1 ESTIMATED U.S. CONSUMPTION OF SPECIALTY BINDERS AND FILLERS BY PRODUCT, 2003
Table 4-5 FORECAST U.S. CONSUMPTION OF SPECIALTY BINDERS AND FILLERS FOR OSDF PHARMACEUTICAL APPLICATIONS, 2003 TO 2008
Table 4-2 U.S. SUPPLIERS OF SPECIALTY BINDERS AND FILLERS TO THE OSDF PHARMACEUTICAL MARKET, 2003
Table 4-3 ESTIMATED U.S. SUPPLIER SALES OF SPECIALTY BINDERS AND FILLERS FOR OSDF PHARMACEUTICAL APPLICATIONS, 2003
Table 4-4 ESTIMATED U.S. SUPPLIER SALES OF SPECIALTY BINDERS AND FILLERS FOR OSDF PHARMACEUTICAL APPLICATIONS, 2003

ALGINATES [US$ 525]

CELLULOSICS [US$ 2 075]

CARBOXYMETHYLCELLULOSE SODIUM [US$ 350]

ETHYL CELLULOSE [US$ 350]

HYDROXYPROPYLCELLULOSE [US$ 350]

HYDROXYPROPYL METHYLCELLULOSE [US$ 350]

METHYLCELLULOSE [US$ 350]

MICROCRYSTALLINE CELLULOSE [US$ 350]

DICALCIUM PHOSPHATE [US$ 525]

DIRECTLY COMPRESSIBLE SUCROSE [US$ 525]

LACTOSE [US$ 525]

POLYOLS [US$ 1 375]

Table 4F-1 SELECTED SORBITOL APPLICATIONS AND USE LEVELS

MANNITOL [US$ 700]

SORBITOL [US$ 700]

POVIDONE [US$ 525]

STARCH [US$ 525]

XANTHAN GUM [US$ 525]

DISINTEGRANTS [US$ 1 375]

CROSPOVIDONE [US$ 475]

CROSCARMELLOSE SODIUM [US$ 475]

SODIUM STARCH GLYCOLATE [US$ 475]

LUBRICANTS: MAGNESIUM STEARATE [US$ 700]

COATINGS [US$ 5 500]

Table 7-1 SELECTED POLYMER FILM FORMERS USED IN COATINGS FOR OSDF APPLICATIONS BY SUPPLIER, 2003
Table 7-2 ESTIMATED SALES OF COATINGS IN THE U.S. MARKET, 2003
Table 7-3 FORECAST GROWTH OF COATINGS IN THE U.S. MARKET BY PRODUCT, 2003 TO 2008

POLYMERS/FILM FORMERS [US$ 2 475]

Table 7A-1 SELECTED COMMERCIAL POLYMERS FOR COATING APPLICATIONS, 2003
Table 7A-2 TABLET FUNCTIONS OF POLYMERS USED AS FILM FORMERS BY TYPE
Table 7A-3 SELECTED POLYMERS USED AS FILM FORMERS FOR OSDF PHARMACEUTICALS IN THE UNITED STATES BY PRODUCT
Table 7A-4 COATING FUNCTIONS OF VARIOUS TYPES OF POLYMETHACRYLATES
Table 7A-5 SELECTED COMMERCIAL POLYMETHACRYLATES FOR COATING APPLICATIONS, 2003

POLYMETHACRYLATES [US$ 625]

HYDROXYPROPYL METHYLCELLULOSE [US$ 625]

ETHYL CELLULOSE [US$ 625]

CELLULOSE ACETATE PHTHALATE [US$ 625]

FORMULATED COATINGS [US$ 1 375]

COATING TYPES [US$ 950]

Table 7C-1 ADVANTAGES AND DISADVANTAGES OF FILM AND SUGAR COATINGS FOR PHARMACEUTICAL DOSAGE FORMS
Table 7C-2 FUNCTIONALITIES OF SELECTED POLYMERS FOR OSDF COATINGS APPLICATIONS, 2003
Table 7C-3 SELECTED PRODUCTS FOR FILM COATING APPLICATIONS
Figure 7C-1 FACTORS INFLUENCING THE SUGAR-COATING PROCESS
Figure 7C-2 LAYERING COMBINATIONS FOR SUGAR-COATING APPLICATIONS
Figure 7C-3 SELECTED RAW MATERIALS FOR SUGAR COATINGS BY COATING CATEGORY

COATING FUNCTIONS

Table 7D-1 REASONS FOR COATING A DOSAGE FORM BY GROUP
Table 7D-2 SELECTED ENTERIC COATING POLYMERS, 2003
Table 7D-3 SELECTED PRODUCTS USED IN SUSTAINED RELEASE COATINGS, 2003

TECHNOLOGY TRENDS

Table 8-1 SELECTED CONTRACT SERVICES/FUNCTIONS WITH EXAMPLES OF OUTSOURCED SPECIALTIES, 2003

PROCUREMENT PRACTICES

Table 9-1 SELECTED CRITERIA RELATING TO SELECTION OF A SPECIALTY EXCIPIENT, 2003

REGULATORY ISSUES

Table 10-1 SUMMARY OF FDA’S GUIDANCE FOR INDUSTRY, SCALE-UP AND POST-APPROVAL CHANGES FOR IMMEDIATE RELEASE ORAL SOLID-DOSAGE FORMS

SUPPLIERS

Table 11-1 ESTIMATED SUPPLIER SALES OF SPECIALTY BINDERS AND FILLERS, DISINTEGRANTS, AND LUBRICANTS FOR OSDF APPLICATIONS, 2003
Table 11-2 ESTIMATED SUPPLIER SALES OF SPECIALTY BINDERS AND FILLERS, DISINTEGRANTS, AND LUBRICANTS FOR OSDF APPLICATIONS, 2003
Table 11-3 ESTIMATED U.S. SUPPLIER SALES OF COATINGS FOR PHARMACEUTICAL APPLICATIONS, 2003

AQUALON [US$ 700]

BASF [US$ 700]

Table 11B-1 ORGANIZATIONAL SCHEME OF BASF, 2003
Figure 11B-1 MEMBERS OF THE BOARD OF EXECUTIVE DIRECTORS OF BASF AND SELECTED MAJOR RESPONSIBILITIES, MAY 2003
Table 11B-2 SELECTED BASF EXCIPIENT PRODUCTS, 2003

CARGILL/CERESTAR [US$ 550]

Table 11C-1 SELECTED MANAGEMENT AND PERSONNEL, 2003
Table 11C-2 SELECTED SPECIALTY EXCIPIENTS MARKETED BY CARGILL, 2003

COLORCON [US$ 700]

Table 11D-1 ELECTED PHARMACEUTICAL PRODUCTS AND TRADE NAMES SUPPLIED BY COLORCON, 2003

DOW CHEMICAL [US$ 700]

Table 11E-1 SELECTED METHOCEL PRODUCTS MARKETED BY DOW CHEMICAL FOR PHARMACEUTICAL APPLICATIONS

EASTMAN CHEMICAL COMPANY [US$ 550]

Table 11F-1 EASTMAN CHEMICAL’S OPERATING SEGMENTS AND CORRESPONDING SALES, 2002

FMC CORPORATION [US$ 700]

INTERNATIONAL SPECIALTY PRODUCTS INC. [US$ 700]

NATIONAL STARCH & CHEMICAL COMPANY [US$ 550]

RETTENMAIER & SOHNE GMBH [US$ 700]

Table 11J-1 LEADING EXCIPIENT PRODUCTS AND TRADE NAMES MARKETED TO PHARMACEUTICAL APPLICATIONS BY JRS, 2003

SHIN-ETSU [US$ 700]

STEP 2 of 3

– Provide your contact information:

All fields in *BOLD are required.

*Name:
*Title:
*Company/Division:
*Address 1 :
Address 2 :
*City:
*State/Province:
*Zip/Postal code:
*Country:
*Phone:
Fax:
*Email:

STEP 3 of 3

– Review and accept our subscription terms and conditions by viewing and clicking below:

*Please view our terms and conditions, and check this box to indicate your acceptance of these terms and conditions.

Thank you for your interest in subscribing to our syndicated reports. To complete this process, please click on the button below and a member of our global sales team will contact you shortly to confirm the final price and complete the transaction. Upon acceptance of your order, we will deliver the files in PDF format via email.

Overview

Industry Practices

Purchasing a Report


	Full Reports Catalog >>

Kline Team Bios

Upcoming Appearances

Our Philosophy


	View all Client Successes >>

	Send a Consulting RFP Purchase a Research Report Request a Meeting General Inquiries

	Questions? Call or Email Us

Market Research: The Global Outlook for Specialty Excipients for Oral Solid-Dosage-Form Pharmaceuticals, Volume I: United States

The Global Outlook for Specialty Excipients for Oral Solid-Dosage-Form Pharmaceuticals, Volume I: United States - Archived Report

ORDER ONLINE

STEP 1 of 3

STEP 2 of 3

STEP 3 of 3

Questions?